About Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde
During the past decade, Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
2017-12-11
2021-02-19
Terminated
446
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde
According to Clinical.Site data, the most researched conditions in "Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde" are
"Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Breast Cancer" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde" in a lesser frequency.
Clinical Trials Intervention Types at Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde
Most popular intervention types in "Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Cobimetinib" (1 trials), "Pembrolizumab" (1 trials), "Trastuzumab Emtansine" (1 trials) and "Vemurafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde
The vast majority of trials in "Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde" are
3 trials for "All" genders.
Clinical Trials Status at Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde
Currently, there are NaN active trials in "Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".